dm+d

39657011000001109

Articles

Preparing Casirivimab 600mg Imdevimab 600mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 600mg Imdevimab 600mg using 11.1mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 1200mg Imdevimab 1200mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 1200mg Imdevimab 1200mg using 11.1mL Vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Handling casirivimab and imdevimab within Trusts

17 September 2021An outline process and supporting materials to help Trusts deploy Ronapreve
Search Articles

Lactation Safety Information

No published evidence for use in breastfeeding
Negligible levels anticipated in milk, and very limited absorption from the infant’s gastro-intestinal tract expected due to the drug’s properties. Therefore, infant side effects are unlikely.
Theoretically, absorption may be increased slightly in the neonatal period due to increased gastrointestinal permeability
Monitor the infant for adequate feeding
Breastfeeding can continue with COVID-19 infection
30 November 2021